BeOne Medicines (ONC) EBT Margin (2015 - 2026)

BeOne Medicines (ONC) has 12 years of EBT Margin data on file, last reported at 17.13% in Q1 2026.

• On a quarterly basis, EBT Margin rose 1526.0% year-over-year to 17.13% in Q1 2026; TTM through Mar 2026 was 11.42%, a 1785.0% increase from a year earlier, with the FY2025 full-year figure at 7.8%, up 2179.0% from the prior year.
• EBT Margin for Q1 2026 stood at 17.13%, up from 9.96% in the prior quarter.
• Over the last five years, EBT Margin for ONC reached as high as 29.35% in Q3 2023 and fell as low as 163.24% in Q2 2022.
• Historically, EBT Margin has averaged 43.14% across 5 years, with a median of 11.4% in 2024.
• Across the five-year window, EBT Margin plunged 14759 bps in 2022 and soared 17156 bps in 2023, its largest moves.
• Year by year, EBT Margin stood at 113.38% in 2022, then soared by 51 bps to 55.29% in 2023, then soared by 86 bps to 7.57% in 2024, then jumped by 232 bps to 9.96% in 2025, then jumped by 72 bps to 17.13% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 17.13% in Q1 2026, 9.96% in Q4 2025, and 10.42% in Q3 2025.